JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99817

Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP)

Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP)

Be the first to review this product! Submit a review

|

(15 Publications)

Mouse Anti-Human IgG4 pFc’ (HRP) is a secondary antibody for chemiluminescent detection. Ideal for Western blot. Suitable for Western blot, IHC, ELISA, ICC and more.

- Cited in over 10 publications

查看别名

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

1 Images
ELISA - Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP) (AB99817)
  • ELISA

Supplier Data

ELISA - Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP) (AB99817)

ELISA plate was coated with purified human IgG1, IgG2, IgG3, and IgG4. Immunoglobulins were detected with serially diluted ab99817.

关键信息

宿主种属

Mouse

靶标种属

Human

靶标亚型

IgG4

靶标特异性

Fc region

最低交叉反应
预吸附

No

偶联物

HRP

激发波长/发射波长
应用

WB, ICC, Dot, ELISA, IHC-Fr

applications

克隆

Monoclonal

克隆号

HP6023

亚型

IgG3

轻链类型

kappa

免疫原

Full Length Protein corresponding to Human IGHG4. The exact immunogen used to generate this antibody is proprietary information.

P01861

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>for Dot and slot immunoblotting.</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/2000", "notes":"<p></p>" } } }

产品详情

This antibody reacts with the pFc' region of Human IgG4

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.4 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

产品实验方案

靶点信息

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

文献 (15)

Recent publications for all applications. Explore the full list and refine your search

British journal of haematology : PubMed40386886

2025

Anti-HSP90α IgG may protect against antiphospholipid syndrome in systemic lupus erythematosus by reducing platelet activation.

Applications

Unspecified application

Species

Unspecified reactive species

Marina Barguil Macêdo,Andreas Jönsen,Anders A Bengtsson,Iva Gunnarsson,Elisabet Svenungsson,Christian Lood

Diabetes, obesity & metabolism 26:1395-1406 PubMed38287130

2024

Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.

Applications

Unspecified application

Species

Unspecified reactive species

Gui-Ling Chen,Yang Liu,Xue-Feng Gao,Kai-Qi Wu,Yun-Kai Yang,Yong Chen,Cong-Gao Peng,Ting-Han Jin,Yu-Bao Huang,Yao-Wen Zhang,Jing Su,Qi Jiang,Tong Guo,Jie Zhao,Xiang-Nan Peng,Jing-Yu Peng,Si-Xiu Li,Yong-Li Sun,Hong-Mei Zhang,Yan-Li Fu,Dan Luo,Yaru Ma,Zhen-Wei Shen,Yun-Tao Zhang,Zhang-Fei Shou

Nature immunology 24:869-883 PubMed37081150

2023

Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jesus Corria-Osorio,Santiago J Carmona,Evangelos Stefanidis,Massimo Andreatta,Yaquelin Ortiz-Miranda,Tania Muller,Ioanna A Rota,Isaac Crespo,Bili Seijo,Wilson Castro,Cristina Jimenez-Luna,Leonardo Scarpellino,Catherine Ronet,Aodrenn Spill,Evripidis Lanitis,Pedro Romero,Sanjiv A Luther,Melita Irving,George Coukos

PloS one 18:e0279389 PubMed36763580

2023

Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshie Gon,Tsugumitsu Kandou,Tatsuaki Tsuruyama,Takeshi Iwasaki,Koji Kitagori,Kosaku Murakami,Ran Nakashima,Shuji Akizuki,Akio Morinobu,Masaki Hikida,Tsuneyo Mimori,Hajime Yoshifuji

Microbial cell factories 20:115 PubMed34107983

2021

Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Xu,Mingyang Shi,Changsheng Shao,Hao Li,Jing Wu,Yin Yu,Fang Fang,Yugang Guo,Weihua Xiao

Viruses 12: PubMed33138336

2020

Association of Genetic Polymorphisms in , , , and with the Clinical Forms of Dengue in Patients from Veracruz, Mexico.

Applications

Unspecified application

Species

Unspecified reactive species

Araceli Posadas-Mondragón,José Leopoldo Aguilar-Faisal,Gerardo Zuñiga,Jonathan Javier Magaña,José Angel Santiago-Cruz,Edith Guillén-Salomón,Verónica Alcántara-Farfán,María Luisa Arellano-Flores,Juan Santiago Salas-Benito,Rocío M Neri-Bazán,Lucero Luna-Rojas,Amanda Marineth Avila-Trejo,Adolfo Chávez-Negrete

Allergy 75:1835-1836 PubMed32652627

2020

Detection of peanut allergens in serum: circumventing the inhibitory effect of immunoglobulins.

Applications

Unspecified application

Species

Unspecified reactive species

Stef J Koppelman,Michel Witteveen,Lonneke JanssenDuijghuijsen,Joseph L Baumert,Renger F Witkamp,Klaske van Norren

Arthritis & rheumatology (Hoboken, N.J.) 72:687-693 PubMed31612628

2020

Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hang Liu,Cory A Perugino,Musie Ghebremichael,Zachary S Wallace,Sydney B Montesi,John H Stone,Shiv Pillai

Arteriosclerosis, thrombosis, and vascular biology 39:1884-1892 PubMed31315438

2019

Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report.

Applications

Unspecified application

Species

Unspecified reactive species

David Henson,Ayman Samman Tahhan,David Nardo,Arshed Ali Quyyumi,Vincent J Venditto

Molecular medicine reports 18:5191-5197 PubMed30272291

2018

Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6‑mediated pathways in vivo and in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Guo-Hua Shi,Lin Zhou
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com